Laura A. Vella

Immunity against Cyclin B1 Tumor Antigen Delays Development of Spontaneous Cyclin B1‐Positive Tumors in p53−/− Mice

Min Yu, O. Finn, Laura A. Vella, 2009, Annals of the New York Academy of Sciences.

Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions

Sasikanth Manne, John P. Reilly, Allison R. Greenplate, 2020, bioRxiv.